Advertisement
Loading...

Trulieve Cannabis Corp.

TCNNFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$9.42
$0.98(11.61%)
U.S. Market is Open • 14:57
Advertisement

Trulieve Cannabis Corp. Fundamental Analysis

Trulieve Cannabis Corp. (TCNNF) shows weak financial fundamentals with a PE ratio of -22.49, profit margin of -6.96%, and ROE of -6.85%. The company generates $1.2B in annual revenue with weak year-over-year growth of 1.30%.

Key Strengths

Cash Position19.39%
PEG Ratio-0.31
Current Ratio5.26

Areas of Concern

ROE-6.85%
We analyze TCNNF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 15.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
15.7/100

We analyze TCNNF's fundamental strength across five key dimensions:

Efficiency Score

Weak

TCNNF struggles to generate sufficient returns from assets.

ROA > 10%
-2.93%

Valuation Score

Excellent

TCNNF trades at attractive valuation levels.

PE < 25
-22.49
PEG Ratio < 2
-0.31

Growth Score

Moderate

TCNNF shows steady but slowing expansion.

Revenue Growth > 5%
1.30%
EPS Growth > 10%
24.39%

Financial Health Score

Excellent

TCNNF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.54
Current Ratio > 1
5.26

Profitability Score

Weak

TCNNF struggles to sustain strong margins.

ROE > 15%
-684.94%
Net Margin ≥ 15%
-6.96%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is TCNNF Expensive or Cheap?

P/E Ratio

TCNNF trades at -22.49 times earnings. This suggests potential undervaluation.

-22.49

PEG Ratio

When adjusting for growth, TCNNF's PEG of -0.31 indicates potential undervaluation.

-0.31

Price to Book

The market values Trulieve Cannabis Corp. at 1.56 times its book value. This may indicate undervaluation.

1.56

EV/EBITDA

Enterprise value stands at 4.84 times EBITDA. This is generally considered low.

4.84

How Well Does TCNNF Make Money?

Net Profit Margin

For every $100 in sales, Trulieve Cannabis Corp. keeps $-6.96 as profit after all expenses.

-6.96%

Operating Margin

Core operations generate 13.57 in profit for every $100 in revenue, before interest and taxes.

13.57%

ROE

Management delivers $-6.85 in profit for every $100 of shareholder equity.

-6.85%

ROA

Trulieve Cannabis Corp. generates $-2.93 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.93%

Following the Money - Real Cash Generation

Operating Cash Flow

Trulieve Cannabis Corp. produces operating cash flow of $278.33M, showing steady but balanced cash generation.

$278.33M

Free Cash Flow

Trulieve Cannabis Corp. generates strong free cash flow of $237.56M, providing ample flexibility for dividends, buybacks, or growth.

$237.56M

FCF Per Share

Each share generates $1.24 in free cash annually.

$1.24

FCF Yield

TCNNF converts 12.88% of its market value into free cash.

12.88%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-22.49

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.31

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.56

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.56

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.54

vs 25 benchmark

Current Ratio

Current assets to current liabilities

5.26

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.07

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

0.06

vs 25 benchmark

How TCNNF Stacks Against Its Sector Peers

MetricTCNNF ValueSector AveragePerformance
P/E Ratio-22.4929.35 Better (Cheaper)
ROE-6.85%705.00% Weak
Net Margin-6.96%-53441.00% (disorted) Weak
Debt/Equity0.540.39 Weak (High Leverage)
Current Ratio5.264.01 Strong Liquidity
ROA-2.93%-19815.00% (disorted) Weak

TCNNF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Trulieve Cannabis Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

36.80%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-211.58%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

65.38%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ